www.cdc.gov: Lighthouse — semaine 2026-W40

166 pages échantillonnées par Google Lighthouse (son propre Chrome sans interface). Les scores vont de 0 à 100 (plus c'est haut, mieux c'est) ; les métriques sont les Core Web Vitals. Télécharger : CSV (scores par page) · JSON (prêt pour l'IA, inclut des recommandations) · CSV des pages prioritaires · JSON des pages prioritaires.

Tendance

Scores par catégorie Lighthouse sur 17 semaines

Scores par catégorie Lighthouse par semaine
Semaine	Performance	Accessibilité	Bonnes pratiques	SEO
2026-W24	82	100	100	100
2026-W25	77	100	96	100
2026-W26	78	100	96	100
2026-W27	80	100	100	100
2026-W28	82	100	96	100
2026-W29	82	100	96	100
2026-W30	84	100	96	100
2026-W31	82	100	96	100
2026-W32	82	100	96	100
2026-W33	77	100	96	100
2026-W34	79	100	96	100
2026-W35	83	100	96	100
2026-W36	86	100	96	100
2026-W37	80	100	96	100
2026-W38	83	100	96	100
2026-W39	80	99	100	100
2026-W40	82	100	100	100

History & Trends → Severity, Lighthouse and other measures across 17 weeks.

Impact sur la performance

How far pages fall short of Google's "good" benchmarks: Largest Contentful Paint ≤ 2.5s and page weight ≤ 1.6 MB. Lower is better.

Avg extra LCP over 2.5s: 3.5s 105/165 pages over
Avg extra weight over 1.6 MB: 3.94 MB 142/193 pages over

Set page_loads_per_week for this target to also estimate total wasted time and data (the way daily-dap uses traffic counts).

Médianes sur les pages échantillonnées

Performance: 82/100
Accessibilité: 100/100
Bonnes pratiques: 100/100
SEO: 100/100
Navigation agentique: 94/100
Plus grand affichage de contenu (LCP): 3.0s
Premier affichage de contenu (FCP): 1.6s
Indice de vitesse: 4.3s
Temps de blocage total: 0.2s
Décalage cumulatif de la mise en page: 0.018

Recommandations

Problèmes signalés par Lighthouse sur les 166 page(s) échantillonnée(s), au-delà des scores principaux — regroupés par catégorie et classés selon le nombre de pages concernées. Les économies estimées (octets transférés ou temps de chargement) sont les propres estimations de Lighthouse lorsqu'elles sont disponibles. Les audits d'accessibilité sont volontairement omis ; ils recoupent les constats d'axe-core sur la page Accessibilité.

Performance

Performance recommandations de Lighthouse, par pages échantillonnées concernées.
Recommandation	Pages	Économie est.
Reduce unused JavaScript	164/166	24.9 MB · 28.9s
JavaScript execution time	163/166	42.8s
Minimize main-thread work	159/166	37.1s
Network dependency tree	158/166	—
Use efficient cache lifetimes	148/166	418.6s
Time to Interactive	140/166	—
Render-blocking requests	126/166	77.8s
Reduce unused CSS	125/166	9.8 MB · 54.5s
Minify JavaScript	107/166	4.4 MB · 10.9s
Largest Contentful Paint	105/166	—
Font display	99/166	5.5s
Speed Index	99/166	—
Avoid multiple page redirects	90/166	70.8s
Improve image delivery	61/166	120.7s
Total Blocking Time	56/166	—
LCP request discovery	52/166	—
Max Potential First Input Delay	51/166	—
Layout shift culprits	50/166	—
First Contentful Paint	49/166	—
Forced reflow	26/166	—
Document request latency	16/166	1.4s
Legacy JavaScript	13/166	1.9s
Page prevented back/forward cache restoration	8/166	—
Initial server response time was short	4/166	0.3s
Minify CSS	2/166	30 KB

Bonnes pratiques

Bonnes pratiques recommandations de Lighthouse, par pages échantillonnées concernées.
Recommandation	Pages	Économie est.
Browser errors were logged to the console	50/166	—
Serves images with low resolution	44/166	—
Page lacks the HTML doctype, thus triggering quirks-mode	40/166	—
Issues were logged in the `Issues` panel in Chrome Devtools	37/166	—
Does not use HTTPS	32/166	—
Displays images with incorrect aspect ratio	22/166	—
Charset declaration is missing or occurs too late in the HTML	19/166	—
Missing source maps for large first-party JavaScript	3/166	—

SEO

SEO recommandations de Lighthouse, par pages échantillonnées concernées.
Recommandation	Pages	Économie est.
Document does not have a meta description	53/166	—
Image elements do not have `[alt]` attributes	32/166	—
Links do not have descriptive text	15/166	—
Links are not crawlable	2/166	—

Agentique (prêt pour l'IA)

Agentique (prêt pour l'IA) recommandations de Lighthouse, par pages échantillonnées concernées.
Recommandation	Pages	Économie est.
WebMCP tools registered	165/166	—
WebMCP form coverage	165/166	—
WebMCP schemas are valid	165/166	—
llms.txt follows recommendations	165/166	—
Cumulative Layout Shift	52/166	—
Accessibility tree is not well-formed	39/166	—

Ce que signifie le score Agentique

Le score Agentique (prêt pour l'IA) est nouveau dans Google Lighthouse (13.4+). Il mesure dans quelle mesure une page fonctionne pour les agents et assistants IA — les outils qui interviennent de plus en plus dans la façon dont les gens trouvent et utilisent les services publics. Il vérifie des éléments comme un fichier llms.txt (un guide lisible par machine pour les modèles de langage), des données structurées valides, un arbre d'accessibilité bien formé que les agents peuvent analyser, et des descriptions d'outils/formulaires WebMCP. Un score plus élevé signifie qu'un assistant IA a plus de chances de comprendre la page et d'accomplir correctement des tâches au nom d'un citoyen.

C'est expérimental et en évolution ; considérez-le comme un signal prospectif, pas comme une exigence de conformité. Médiane sur les pages échantillonnées : 94/100.

Lacunes trouvées sur les pages échantillonnées : WebMCP tools registered (165), WebMCP form coverage (165), WebMCP schemas are valid (165), llms.txt follows recommendations (165), Cumulative Layout Shift (52), Accessibility tree is not well-formed (39).

Résultats par page

Scores Lighthouse et Core Web Vitals par page échantillonnée (2026-W40). Agentique = score expérimental de navigation agentique. La préparation PWA / hors ligne est suivie dans l'onglet Standards (Lighthouse 12+ a supprimé la catégorie PWA). — cliquez sur un en-tête de colonne pour trier

/acute-bronchitis/about/index.html	90	100	100	100	100	1.2s	3.0s	4.3s	0.2s	0.003
/vaccines/hcp/by-disease/hib.html	89	100	100	100	96	1.8s	2.4s	4.4s	0.2s	0.089
/mmwr/preview/mmwrhtml/00053877.htm	100	62	63	83	100	1.3s	1.3s	1.3s	0.1s	0
/national-asthma-control-program/site.html	95	100	100	100	100	1.2s	2.0s	3.8s	0.2s	0.013
/niosh/publications/numbered/2014-149.html	89	100	100	100	47	1.3s	2.9s	4.7s	0.1s	0.08
/pcd/issues/2009/jan/08_0020_fr.htm	99	66	67	83	50	1.1s	1.7s	1.1s	0.1s	0
/mmwr/preview/mmwrhtml/ss5709a3.htm	89	59	67	83	100	1.1s	3.8s	1.3s	0.0s	0
/PCD/issues/2010/may/09_0164.htm	99	70	67	83	50	1.3s	1.4s	1.3s	0.1s	0
/niosh-rtecs/KN657890.html	74	96	100	100	36	2.1s	3.9s	4.3s	0.2s	0.168
/mmwr/preview/mmwrhtml/mm5446md.htm	100	59	62	83	100	0.8s	1.8s	0.8s	0.1s	0
/diabetes/es/diabetes-complications/la-diabetes-y-la-salud-oral.html	82	100	100	100	100	1.7s	3.4s	6.0s	0.2s	0.003
/niosh/fedreg.html	79	100	100	100	98	1.7s	4.0s	5.8s	0.2s	0.071
/mmwr/mmwr_additional_resources.html	32	100	96	100	51	2.2s	8.6s	4.3s	0.6s	1.008
/mmwr/preview/mmwrhtml/rr5217a1.htm	97	62	65	83	100	1.4s	2.1s	1.4s	0.1s	0
/antimicrobial-resistance-laboratory-networks/es/site.html	84	100	100	100	100	1.2s	2.0s	4.8s	0.5s	0.003
/diabetes/living-with/mental-health.html	76	100	100	100	96	1.6s	4.4s	4.8s	0.2s	0.089
/lead-prevention/php/data/nhanes.html	89	100	100	100	100	1.6s	2.9s	4.9s	0.2s	0.003
/mmwr/preview/mmwrhtml/mm5312a5.htm	100	59	62	83	100	1.2s	1.2s	1.2s	0.0s	0
/mmwr/volumes/71/wr/mm7101a2.htm	65	95	96	100	76	2.3s	4.0s	2.3s	0.3s	0.241
/media/es/releases/2024/m1924-casograve-h5n1.html	93	100	100	100	100	1.6s	2.3s	5.0s	0.1s	0.032
/bird-flu/about/avian-influenza-type-a.html	66	91	100	85	50	2.2s	15.3s	6.4s	0.1s	0.009
/howrightnow/gratitude/index.html	46	100	96	100	54	2.1s	33.1s	2.4s	0.2s	0.653
/muscular-dystrophy/hcp/clinical-overview/index.html	75	100	100	100	91	1.6s	3.6s	4.8s	0.3s	0.132
/diabetes/signs-symptoms/index.html	77	100	100	100	85	1.6s	3.7s	5.1s	0.1s	0.174
/polaris/php/economics/cost-analysis.html	78	100	100	100	84	1.2s	3.6s	4.1s	0.2s	0.175
/pcd/issues/2005/apr/04_0142o_zht.htm	99	66	65	83	50	0.8s	0.9s	0.8s	0.1s	0
/stophivtogether/spanish/preparado/index.html	40	90	92	92	30	2.0s	7.3s	7.6s	0.7s	0.209
/niosh/fedreg.html	81	100	100	100	96	1.2s	3.9s	4.0s	0.2s	0.092
/niosh/idlh/107051.html	81	100	100	100	69	1.8s	2.0s	1.9s	0.2s	0.307
/mmwr/volumes/71/wr/mm7138e2.htm	61	98	96	100	71	2.3s	4.1s	2.3s	0.4s	0.287
/brfss/acbs/2017/multiple_year/acbs_prevalence_15-17_table2a.html	39	96	100	92	54	2.7s	6.6s	5.7s	0.3s	0.658
/cannabis/health-effects/cannabis-use-disorder.html	95	100	100	100	100	1.2s	1.4s	5.0s	0.1s	0.046
/laboratory-systems/php/about	95	100	100	100	100	1.2s	2.0s	3.9s	0.2s	0.004
/mmwr/volumes/70/wr/mm7040e3.htm	33	98	96	100	100	6.7s	34.3s	10.6s	1.1s	0
/mmwr/preview/mmwrhtml/00000883.htm	100	55	63	83	100	1.2s	1.3s	1.2s	0.1s	0
/pcd/issues/2007/oct/07_0021.htm	98	70	65	83	50	1.0s	1.1s	1.0s	0.2s	0
/faca/committees/acip.html	94	100	100	100	100	1.6s	2.3s	4.0s	0.2s	0.016
/nchs/injury/injury_links.htm	68	100	96	92	68	2.3s	3.1s	2.3s	0.3s	0.328
/acip/evidence-to-recommendations/pneumo-PCV15-PPSV23-age-based-etr.html	92	100	100	100	100	1.7s	2.4s	4.7s	0.2s	0.014
/pcd/issues/2005/jan/04_0105.htm	100	66	67	83	50	1.2s	1.4s	1.2s	0.1s	0
/flu-vaccines-work/index.html	65	91	100	85	50	2.2s	15.2s	6.6s	0.2s	0.009
/mmwr/preview/mmwrhtml/mm6013a2.htm	98	79	85	92	50	1.4s	2.2s	1.4s	0.1s	0
/covid/vaccines	88	100	100	100	96	1.2s	2.9s	4.9s	0.1s	0.094
/leishmaniasis/about/index.html	86	100	100	100	93	1.2s	3.0s	4.8s	0.1s	0.117
/niosh/bulletin/2021/opioids-in-construction.html	91	100	100	100	96	1.5s	1.6s	5.6s	0.1s	0.094
/hepatitis-b/about/index.html	67	91	100	85	50	2.2s	12.4s	6.5s	0.1s	0.009
/early-care-education/php/data-research/index.html	84	100	100	100	100	1.5s	3.5s	5.5s	0.1s	0.035
/dengue/stories/integrated-mosquito-control.html	68	100	100	100	94	1.2s	6.5s	5.7s	0.1s	0.109
/pinkbook/hcp/table-of-contents	88	100	100	100	100	1.7s	2.7s	5.0s	0.2s	0.002
/niosh/docs/wp-solutions/2024-123	87	100	100	100	50	1.7s	3.5s	4.5s	0.1s	0.004
/overdose-resources/index.html	46	100	100	92	62	1.2s	35.9s	9.1s	0.1s	0.411
/mmwr/preview/mmwrhtml/mm6309a4.htm	83	79	85	92	50	1.8s	4.4s	2.6s	0.1s	0
/chickenpox/hcp/clinical-overview/index.html	64	100	100	100	100	1.4s	11.4s	6.0s	0.3s	0.044
/mmwr/preview/mmwrhtml/mm6249a5.htm	95	78	85	92	50	1.8s	2.7s	1.8s	0.1s	0
/nchs/products/databriefs/db407.htm	28	100	96	100	57	5.0s	31.4s	5.0s	0.5s	0.53
/niosh/idlh/110430.html	70	100	100	100	65	2.7s	3.0s	2.7s	0.2s	0.357
/von-willebrand/about/index.html	73	100	100	100	96	1.2s	5.6s	4.5s	0.1s	0.094
/act-early/milestones/4-years.html	53	96	96	100	97	1.4s	7.2s	18.0s	0.5s	0.082
/nssp/php/onboarding-toolkits/data-quality.html	94	100	100	100	100	1.4s	2.3s	4.6s	0.1s	0.001
/acip/grade/cholera-cvd-103-hgr-child-2-17-years.html	91	97	100	100	100	1.7s	2.5s	4.7s	0.2s	0.012
/mmwr/volumes/69/ss/ss6909a1.htm	64	98	96	100	71	2.1s	3.2s	2.1s	0.5s	0.287
/flu/whats-new/2023-2024-flu-heart-study.html	71	100	100	100	100	1.6s	3.0s	6.0s	0.7s	0.009
/emerging-infections-program/site.html	91	100	100	100	100	1.6s	2.8s	3.4s	0.2s	0.003
/niosh/publications/numbered/2023-123.html	70	100	100	100	34	1.6s	4.6s	4.3s	0.2s	0.181
/mmwr/preview/mmwrhtml/mm6302a5.htm	97	84	85	92	50	1.8s	2.2s	1.8s	0.1s	0.005
/traumatic-brain-injury/signs-symptoms/index.html	45	100	100	100	100	2.3s	28.1s	7.1s	0.9s	0
/thalassemia/communication-resources/initiating-regular-transfusions.html	94	100	100	100	100	1.6s	2.3s	4.1s	0.2s	0.019
/hiv/treatment/index.html	49	89	93	100	17	1.7s	13.8s	6.2s	0.2s	0.338
/mmwr/preview/mmwrhtml/00015127.htm	61	59	63	83	100	2.7s	5.5s	4.4s	0.5s	0
/mmwr/volumes/71/wr/mm7110a3.htm	59	98	96	100	67	2.9s	4.2s	2.9s	0.3s	0.335
/group-a-strep/about/strep-throat.html	65	91	100	85	50	2.2s	15.0s	7.2s	0.1s	0.009
/pulsenet/about/index.html	80	100	100	100	98	1.6s	3.4s	5.1s	0.3s	0.075
/diabetes/caring/5-questions-health-care-team.html	79	100	100	100	93	1.6s	3.5s	5.7s	0.2s	0.114
/adenovirus/about/index.html	87	100	100	100	94	1.2s	3.2s	4.0s	0.1s	0.111
/mmwr/preview/mmwrhtml/mm5644a1.htm	100	62	67	83	100	1.2s	1.3s	1.2s	0.1s	0
/niosh/bulletin/2023/cannabis-allergies.html	92	100	100	100	100	1.6s	2.0s	5.0s	0.2s	0.035
/mmwr/volumes/65/wr/mm6519a2.htm	69	95	96	92	71	2.0s	3.6s	2.1s	0.2s	0.287
/importation/index.html	75	100	100	92	100	1.6s	5.7s	4.6s	0.1s	0.002
/mmwr/preview/mmwrhtml/00000353.htm	100	62	62	83	100	0.8s	1.0s	0.8s	0.0s	0
/niosh/docs/2016-106/default.html	92	100	100	100	100	1.7s	2.2s	4.8s	0.2s	0.037
/nchs/products/databriefs/db399.htm	45	100	96	100	58	2.7s	7.4s	2.7s	0.3s	0.497
/mmwr/volumes/66/wr/mm6640a3.htm	81	95	96	92	74	2.0s	2.0s	2.1s	0.2s	0.263
/mmwr/volumes/70/wr/mm7033a2.htm	69	98	96	100	76	2.0s	4.0s	2.0s	0.3s	0.239
/readiness/php/testgame/test-pod-discussion-guide.html	71	100	100	100	100	1.2s	2.7s	5.9s	0.9s	0.012
/heat-health/es/risk-factors/la-mascotas-y-el-calor.html	93	100	100	100	100	1.2s	2.3s	5.0s	0.1s	0.035
/flu/weekly/weeklyarchives2023-2024/week29.htm	52	99	96	100	64	2.2s	6.9s	2.2s	0.2s	0.385
/nchs/pressroom/stats_of_the_states.htm	34	100	96	100	100	2.3s	31.7s	9.8s	2.8s	0
/mmwr/preview/mmwrhtml/mm6246a6.htm	95	79	85	92	50	1.8s	2.6s	1.8s	0.1s	0
/pcd/issues/2011/may/10_0163_es.htm	99	66	65	83	50	0.8s	1.3s	0.8s	0.1s	0
/mers/site.html	95	100	100	100	100	1.2s	2.0s	4.3s	0.2s	0.003
/mmwr/index2018.html	51	100	96	100	65	1.8s	6.8s	1.8s	0.3s	0.358
/mmwr/preview/mmwrhtml/00000900.htm	100	62	63	83	100	1.1s	1.1s	1.1s	0.0s	0
/mmwr/preview/mmwrhtml/00018113.htm	100	62	63	83	100	1.2s	1.3s	1.2s	0.0s	0
/pcd/issues/2021/20_0362.htm	51	100	92	100	52	1.7s	6.8s	2.1s	0.1s	0.896
/school-health-profiles/methods/2022-response-rate.html	96	100	100	100	100	1.6s	2.0s	4.2s	0.0s	0.023
/monkeypox/hcp/clinical-care/pregnancy.html	91	100	100	100	100	1.7s	2.5s	4.8s	0.2s	0.012
/mmwr/volumes/65/wr/mm6526a1.htm	74	95	96	100	72	2.0s	2.6s	2.0s	0.3s	0.283
/asthma-data/reports-publications/index.html	77	100	96	100	100	1.5s	2.9s	5.4s	0.5s	0.003
/pcd/issues/2018/18_0062.htm	47	100	96	100	54	2.1s	6.9s	2.3s	0.2s	0.7
/pcd/issues/2008/jul/07_0138_zhs.htm	98	66	65	83	50	0.9s	1.2s	0.9s	0.1s	0
/scientific-integrity/php/human-subjects-protection	93	100	100	100	100	1.7s	2.5s	4.2s	0.1s	0.013
/mmwr/volumes/67/wr/mm6716a3.htm	76	98	96	100	76	2.0s	2.7s	2.0s	0.3s	0.239
/vaccines-for-children/about/index.html	79	100	100	100	96	1.6s	4.3s	4.6s	0.1s	0.092
/orr/responses/multistate-meningitis-outbreak.html	81	100	96	100	94	1.3s	2.6s	5.4s	0.3s	0.111
/niosh/docs/2019-118	83	100	100	100	43	1.7s	3.4s	5.7s	0.1s	0.114
/flu/prevention/index.html	66	91	100	85	50	2.3s	8.7s	6.7s	0.1s	0.009
/think-test-treat-tb/about/index.html	62	96	96	100	93	1.2s	5.8s	5.8s	0.3s	0.113
/niosh/docs/2021-120/default.html	87	100	100	100	39	1.3s	2.3s	5.7s	0.0s	0.145
/nhsn/ltc/newsletters/dec19-newsletter-ltc.html	62	100	96	100	61	2.0s	3.8s	2.0s	0.3s	0.441
/about/divisions-offices/ophdst.html	94	100	100	100	100	1.6s	2.0s	4.7s	0.1s	0.043
/vaccines/hcp/administration/before.html	65	91	100	85	50	2.2s	12.8s	7.2s	0.1s	0.009
/mmwr/preview/mmwrhtml/mm5315a7.htm	100	62	65	83	100	0.9s	1.1s	0.9s	0.1s	0
/niosh/publications/numbered/2005-138.html	77	100	100	100	100	1.2s	3.9s	5.3s	0.3s	0.003
/niosh/npptl/topics/respirators	69	100	100	100	100	1.7s	7.9s	5.2s	0.2s	0.003
/tularemia/about/index.html	81	100	100	100	94	1.6s	3.7s	4.8s	0.1s	0.106
/mmwr/preview/mmwrhtml/mm5908a4.htm	94	79	85	92	50	1.5s	2.9s	1.5s	0.1s	0
/mmwr/volumes/71/rr/rr7101a1.htm	58	98	96	100	66	2.0s	3.6s	2.0s	0.6s	0.356
/nchs/pressroom/calendar/2026_schedule.htm	47	93	96	92	14	2.4s	7.6s	3.6s	0.3s	0.371
/mmwr/preview/mmwrhtml/mm5301a1.htm	100	62	65	75	100	0.8s	1.1s	0.8s	0.1s	0
/niosh/docs/2005-124	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a	n/a
/mmwr/volumes/69/wr/mm6913a1.htm	73	98	96	100	71	2.0s	2.6s	2.0s	0.3s	0.287
/pcd/issues/2008/jul/07_0104.htm	100	70	65	83	50	1.0s	1.1s	1.0s	0.1s	0
/media/es/releases/2026/nuevo-retiro-del-mercado-en-brote-de-salmonella-vinculado-a-suplementos-alimenticios-que-contienen.html	85	100	100	100	100	1.6s	2.9s	5.7s	0.2s	0.021
/niosh/publications/numbered/2014-127.html	72	100	100	100	100	1.3s	26.6s	4.5s	0.1s	0.017
/mmwr/volumes/69/wr/mm6914a5.htm	60	98	96	100	66	2.1s	3.5s	2.1s	0.5s	0.355
/mmwr/preview/mmwrhtml/mm5506a1.htm	100	62	65	83	100	0.8s	1.4s	0.8s	0.0s	0
/monkeypox/php/monitoring/index.html	94	100	100	100	100	1.6s	2.3s	4.1s	0.2s	0.012
/bird-flu/spotlights/bird-flu-surveillance.html	94	100	100	100	100	1.2s	2.1s	4.8s	0.1s	0.006
/pinkbook/hcp/table-of-contents/chapter-18-poliomyelitis.html	94	100	100	100	100	1.7s	2.3s	3.9s	0.1s	0.005
/asthma/nhis/2019/table6-1.htm	57	96	100	100	62	2.0s	5.0s	2.0s	0.2s	0.421
/mmwr/preview/mmwrhtml/00001615.htm	100	62	62	83	100	1.1s	1.2s	1.1s	0.1s	0
/schistosomiasis/about/index.html	66	91	100	85	50	2.1s	14.4s	6.5s	0.1s	0.009
/mmwr/preview/mmwrhtml/mm6425a8.htm	83	84	85	92	50	1.6s	4.0s	4.1s	0.1s	0
/water-emergency/about	93	100	100	100	100	1.2s	2.6s	5.0s	0.1s	0
/mmwr/volumes/74/wr/mm7412a3.htm	55	98	96	100	100	6.6s	32.0s	6.8s	0.2s	0
/botulism/php/national-botulism-surveillance	82	100	100	100	96	1.2s	3.3s	5.6s	0.2s	0.089
/niosh/heat-stress/es/recursos/comunicar.html	87	100	100	100	100	1.6s	2.1s	6.3s	0.3s	0.008
/brfss/data_documentation/index.htm	57	100	96	100	67	1.8s	2.9s	2.1s	0.9s	0.337
/mmwr/preview/mmwrhtml/mm6012a1.htm	97	79	85	92	50	1.8s	2.3s	1.8s	0.1s	0
/mmwr/preview/mmwrhtml/mm5044a2.htm	100	62	65	83	100	0.8s	1.1s	0.8s	0.1s	0
/acip/meetings/presentation-slides-october-25-26-2023.html	92	100	100	100	100	1.2s	2.0s	4.7s	0.2s	0.011
/lyme/data-research/facts-stats/surveillance-data-1.html	65	91	100	85	50	2.2s	15.3s	7.3s	0.1s	0.009
/healthy-youth/communication-resources/index.html	50	100	100	100	70	1.3s	16.8s	7.7s	0.2s	0.305
/mmwr/preview/mmwrhtml/00051740.htm	100	62	62	83	100	0.9s	0.9s	0.9s	0.1s	0
/mmwr/preview/mmwrhtml/00046958.htm	73	62	63	83	100	1.6s	4.6s	2.4s	0.4s	0
/mmwr/preview/mmwrhtml/mm4837a3.htm	100	62	67	83	100	1.1s	1.1s	1.1s	0.1s	0
/mmwr/preview/mmwrhtml/mm4943a2.htm	100	62	67	83	100	1.1s	1.6s	1.1s	0.1s	0
/mmwr/preview/mmwrhtml/mm5531md.htm	93	59	62	83	100	0.9s	3.2s	1.1s	0.1s	0
/acip/evidence-to-recommendations/nirsevimab-season2-rsv-infants-children-etr.html	87	100	100	100	100	1.8s	3.2s	4.6s	0.2s	0.033
/mmwr/volumes/65/wr/mm6502a3.htm	71	98	96	100	72	2.0s	3.3s	2.1s	0.3s	0.277
/mmwr/preview/mmwrhtml/mm5651a7.htm	99	51	65	75	48	0.9s	1.1s	0.9s	0.0s	0.067
/brfss/acbs/2006/prevalence_tables/table11b.html	48	96	96	92	51	2.3s	5.6s	2.3s	0.2s	1.259
/toxocariasis/site.html	93	100	100	100	100	1.3s	2.1s	5.1s	0.2s	0.019
/mosquitoes/mosquito-control/community/adulticides.html	68	100	96	100	96	1.2s	5.0s	7.3s	0.2s	0.089
/dpdx/clonorchiasis/index.html	54	90	100	92	36	4.3s	31.0s	4.3s	0.2s	0.165
/locs/php/clcr-calls/2020/2020-05-11.html	85	100	100	100	100	1.2s	3.5s	4.8s	0.2s	0.042
/brfss/acbs/2020/prevalence_tables/table9_LLCP.html	51	100	100	100	53	2.4s	3.2s	2.4s	0.6s	0.779
/mmwr/volumes/73/ss/ss7307a1.htm	66	98	96	100	76	2.0s	2.9s	2.0s	0.6s	0.239
/niosh/docs/mining/works/coversheet1118.html	68	100	100	100	50	1.2s	10.8s	6.3s	0.1s	0.042
/botulism/diagnosing-treating/index.html	83	100	100	100	94	1.5s	3.3s	4.2s	0.2s	0.106
/pcd/issues/2006/jan/05_0109.htm	99	70	67	83	50	1.3s	1.5s	1.3s	0.1s	0
/niosh/ptd/awards	78	100	100	92	99	1.4s	4.9s	4.3s	0.1s	0.065
/pcd/issues/2009/jan/08_0006_fr.htm	100	66	67	83	50	1.1s	1.4s	1.1s	0.1s	0
/media/index.html	76	100	100	92	100	1.2s	3.4s	4.5s	0.5s	0.018
/niosh/docs/wp-solutions/2017-113	91	96	100	100	50	1.2s	2.8s	4.2s	0.2s	0.007
/psittacosis/php/laboratories/index.html	65	100	100	100	100	1.6s	46.7s	8.5s	0.2s	0.012